20 results
8-K
EX-10.1
ARCT
Arcturus Therapeutics Holdings Inc
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
of the Company or any of its Subsidiaries is represented by a union and, to the knowledge of the Company, no union organizing activities are taking place … Control of the United States Department of the Treasury), the United Nations Security Council, the European Union, Her Majesty’s Treasury or other
10-K
2019 FY
ARCT
Arcturus Therapeutics Holdings Inc
16 Mar 20
Annual report
11:09am
like the IND prior to the commencement of human clinical trials. In the European Union, for example, a CTA must be submitted to each country’s … of an investigational drug or biological product under European Union regulatory systems, we or our strategic alliance partners must submit a marketing authorization
8-K
EX-1.1
tg1v 5ibwtsn
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-1.1
ad0z o9dr8codeu
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
622z0
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
S-4
ia8xr4txdabi8vj8l7
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
424B3
ztl7v4
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
hj1jvbt fm8hu5g9
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
8-K
EX-10.1
2857d1 5kbqltz
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
eu4cv1cp 0yemox
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-10.1
pirdyrgph x76x4
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
- Prev
- 1
- Next